R Brett McQueen, Nai-Chia Chen, Eric J Gutierrez, Kelly E Anderson, G Todd Alonso
{"title":"Identifying diabetic ketoacidosis encounters at diagnosis among children with type 1 diabetes in claims data.","authors":"R Brett McQueen, Nai-Chia Chen, Eric J Gutierrez, Kelly E Anderson, G Todd Alonso","doi":"10.1210/jendso/bvag146","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Quantify the performance of claims data in identifying diabetic ketoacidosis (DKA) cases and estimate healthcare resource utilization among newly diagnosed type 1 diabetes patients with and without DKA.</p><p><strong>Methods: </strong>We matched individuals <18 years of age from the Barbara Davis Center for Diabetes Registry to the Colorado all-payer claims database to estimate variation in the performance of claims (ie, type 1 diabetes and DKA codes in emergency department [ER] and inpatient [IP] settings) in identifying DKA cases from 2014 to 2019. We estimated the unadjusted and adjusted associations of laboratory-confirmed DKA with resource utilization using encounters and incidence rate ratios with 95% confidence intervals.</p><p><strong>Results: </strong>After applying algorithms for identifying type 1 diabetes with continuous enrollment criteria, n = 728 (62% match of the sample) represented an insured population residing in Colorado. Mean age at onset was approximately 9.48 years, with a proportion of DKA events at diagnosis of 56%. Strict coding definitions of DKA (DKA and type 1 diabetes) had lower sensitivity (63%) and higher specificity (76%) than looser definitions (type 1 diabetes or DKA), which had higher sensitivity (89%) and lower specificity (60%). Laboratory-confirmed DKA was associated with over 5 times the rate of IP encounters compared with no confirmed DKA (incidence rate ratio [IRR], 5.49; 95% confidence interval, 4.03-7.47) but fewer ER-only encounters (IRR, 0.36; 95% confidence interval, 0.24-0.54).</p><p><strong>Conclusion: </strong>Claims data may not capture all DKA encounters at type 1 diabetes diagnosis. Future research should provide sensitivity analyses across coding and settings to estimate the burden of DKA.</p>","PeriodicalId":17334,"journal":{"name":"Journal of the Endocrine Society","volume":"10 8","pages":"bvag146"},"PeriodicalIF":4.4000,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13366538/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Endocrine Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/jendso/bvag146","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Quantify the performance of claims data in identifying diabetic ketoacidosis (DKA) cases and estimate healthcare resource utilization among newly diagnosed type 1 diabetes patients with and without DKA.
Methods: We matched individuals <18 years of age from the Barbara Davis Center for Diabetes Registry to the Colorado all-payer claims database to estimate variation in the performance of claims (ie, type 1 diabetes and DKA codes in emergency department [ER] and inpatient [IP] settings) in identifying DKA cases from 2014 to 2019. We estimated the unadjusted and adjusted associations of laboratory-confirmed DKA with resource utilization using encounters and incidence rate ratios with 95% confidence intervals.
Results: After applying algorithms for identifying type 1 diabetes with continuous enrollment criteria, n = 728 (62% match of the sample) represented an insured population residing in Colorado. Mean age at onset was approximately 9.48 years, with a proportion of DKA events at diagnosis of 56%. Strict coding definitions of DKA (DKA and type 1 diabetes) had lower sensitivity (63%) and higher specificity (76%) than looser definitions (type 1 diabetes or DKA), which had higher sensitivity (89%) and lower specificity (60%). Laboratory-confirmed DKA was associated with over 5 times the rate of IP encounters compared with no confirmed DKA (incidence rate ratio [IRR], 5.49; 95% confidence interval, 4.03-7.47) but fewer ER-only encounters (IRR, 0.36; 95% confidence interval, 0.24-0.54).
Conclusion: Claims data may not capture all DKA encounters at type 1 diabetes diagnosis. Future research should provide sensitivity analyses across coding and settings to estimate the burden of DKA.